Loading clinical trials...
Loading clinical trials...
A Phase II Study of CPX-351 Monotherapy in Acute Myeloid Leukemia
Conditions
Interventions
CPX-351
Locations
34
France
AMIENS - CHU Amiens Picardie
Amiens, France
ANGERS - CHU - Maladies du sang
Angers, France
AVIGNON - Centre Hospitalier
Avignon, France
BAYONNE - CH de la Côte Basque - Hématologie
Bayonne, France
AVICENNE - Centre de Recherche Clinique
Bobigny, France
BREST - Hôpital Morvan
Brest, France
Start Date
March 23, 2022
Primary Completion Date
October 15, 2023
Completion Date
December 4, 2023
Last Updated
October 29, 2024
NCT06285890
NCT06220162
NCT04065399
NCT06484062
NCT06994676
NCT04628026
Lead Sponsor
French Innovative Leukemia Organisation
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions